FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200147166> ?p ?o ?g. }

• W3200147166 endingPage "590" @default.
• W3200147166 startingPage "585" @default.
• W3200147166 abstract "Purpose Nivolumab is an anti-programmed cell death protein 1 (PD1) monoclonal antibody that is indicated in relapsed/refractory Hodgkin lymphoma (R/R HL) after autologous stem cell transplant (autoSCT). Purpose of our retrospective study was to assess safety and efficacy of Nivolumab in R/R HL as a bridge to autoSCT in patients who are refractory to ≥ 2 lines of chemotherapy. Methods Demographic data, number of chemotherapy regimens given previously, number of Nivolumab doses taken, and disease status on PET/CT were noted. Nivolumab was administered as a 3 mg/kg IV infusion every 2 weeks. The immunotherapy related adverse events (irAEs) were noted if any and documented. Results A total of 16 patients were included in the study. Ten patients were male and 6 were female. Median age was 22 years (range 3-32 years). The median number of treatment lines prior to Nivolumab was 3 (range 2-7). Nine patients had Complete Response (CR), 3 had Partial response (PR), 2 had Stable Disease (SD), 1 patient had pseudo-progression; classified as IR (3) and 1 expired before end of treatment evaluation. The drug was well tolerated, with mild irAEs noted. Twelve patients (75%) successfully underwent autoSCT. At a median follow up of 17.5 months (range 0.5-35 months), the progression- free survival (PFS) was 75% and overall survival (OS) was 87.5%. Conclusion Nivolumab is effective and safe in patients with R/R HL and is a good bridging therapy to autoSCT." @default.
• W3200147166 created "2021-09-27" @default.
• W3200147166 creator A5006800273 @default.
• W3200147166 creator A5011235945 @default.
• W3200147166 creator A5016024500 @default.
• W3200147166 creator A5023370091 @default.
• W3200147166 creator A5036708296 @default.
• W3200147166 creator A5046604590 @default.
• W3200147166 creator A5048445348 @default.
• W3200147166 creator A5050618790 @default.
• W3200147166 creator A5065334941 @default.
• W3200147166 creator A5065552617 @default.
• W3200147166 creator A5086271326 @default.
• W3200147166 date "2021-09-20" @default.
• W3200147166 modified "2023-10-09" @default.
• W3200147166 title "Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma" @default.
• W3200147166 cites W1978864445 @default.
• W3200147166 cites W2006204796 @default.
• W3200147166 cites W2081427287 @default.
• W3200147166 cites W2119147717 @default.
• W3200147166 cites W2125616358 @default.
• W3200147166 cites W2133201432 @default.
• W3200147166 cites W2150379694 @default.
• W3200147166 cites W2167555906 @default.
• W3200147166 cites W2504623699 @default.
• W3200147166 cites W2514468425 @default.
• W3200147166 cites W2552995821 @default.
• W3200147166 cites W2593533764 @default.
• W3200147166 cites W2598700764 @default.
• W3200147166 cites W2731673561 @default.
• W3200147166 cites W2752453328 @default.
• W3200147166 cites W2794872274 @default.
• W3200147166 cites W2797608577 @default.
• W3200147166 cites W2911651696 @default.
• W3200147166 cites W2952585764 @default.
• W3200147166 cites W2968942240 @default.
• W3200147166 doi "https://doi.org/10.1007/s12288-021-01490-1" @default.
• W3200147166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35747573" @default.
• W3200147166 hasPublicationYear "2021" @default.
• W3200147166 type Work @default.
• W3200147166 sameAs 3200147166 @default.
• W3200147166 citedByCount "1" @default.
• W3200147166 countsByYear W32001471662023 @default.
• W3200147166 crossrefType "journal-article" @default.
• W3200147166 hasAuthorship W3200147166A5006800273 @default.
• W3200147166 hasAuthorship W3200147166A5011235945 @default.
• W3200147166 hasAuthorship W3200147166A5016024500 @default.
• W3200147166 hasAuthorship W3200147166A5023370091 @default.
• W3200147166 hasAuthorship W3200147166A5036708296 @default.
• W3200147166 hasAuthorship W3200147166A5046604590 @default.
• W3200147166 hasAuthorship W3200147166A5048445348 @default.
• W3200147166 hasAuthorship W3200147166A5050618790 @default.
• W3200147166 hasAuthorship W3200147166A5065334941 @default.
• W3200147166 hasAuthorship W3200147166A5065552617 @default.
• W3200147166 hasAuthorship W3200147166A5086271326 @default.
• W3200147166 hasBestOaLocation W32001471662 @default.
• W3200147166 hasConcept C121332964 @default.
• W3200147166 hasConcept C121608353 @default.
• W3200147166 hasConcept C126322002 @default.
• W3200147166 hasConcept C141071460 @default.
• W3200147166 hasConcept C142424586 @default.
• W3200147166 hasConcept C143998085 @default.
• W3200147166 hasConcept C197934379 @default.
• W3200147166 hasConcept C2776694085 @default.
• W3200147166 hasConcept C2777701055 @default.
• W3200147166 hasConcept C2779050716 @default.
• W3200147166 hasConcept C2779338263 @default.
• W3200147166 hasConcept C2780030458 @default.
• W3200147166 hasConcept C71924100 @default.
• W3200147166 hasConcept C87355193 @default.
• W3200147166 hasConceptScore W3200147166C121332964 @default.
• W3200147166 hasConceptScore W3200147166C121608353 @default.
• W3200147166 hasConceptScore W3200147166C126322002 @default.
• W3200147166 hasConceptScore W3200147166C141071460 @default.
• W3200147166 hasConceptScore W3200147166C142424586 @default.
• W3200147166 hasConceptScore W3200147166C143998085 @default.
• W3200147166 hasConceptScore W3200147166C197934379 @default.
• W3200147166 hasConceptScore W3200147166C2776694085 @default.
• W3200147166 hasConceptScore W3200147166C2777701055 @default.
• W3200147166 hasConceptScore W3200147166C2779050716 @default.
• W3200147166 hasConceptScore W3200147166C2779338263 @default.
• W3200147166 hasConceptScore W3200147166C2780030458 @default.
• W3200147166 hasConceptScore W3200147166C71924100 @default.
• W3200147166 hasConceptScore W3200147166C87355193 @default.
• W3200147166 hasIssue "3" @default.
• W3200147166 hasLocation W32001471661 @default.
• W3200147166 hasLocation W32001471662 @default.
• W3200147166 hasLocation W32001471663 @default.
• W3200147166 hasOpenAccess W3200147166 @default.
• W3200147166 hasPrimaryLocation W32001471661 @default.
• W3200147166 hasRelatedWork W2800160190 @default.
• W3200147166 hasRelatedWork W2890849069 @default.
• W3200147166 hasRelatedWork W2898986397 @default.
• W3200147166 hasRelatedWork W2914827752 @default.
• W3200147166 hasRelatedWork W2976744492 @default.
• W3200147166 hasRelatedWork W2981652925 @default.
• W3200147166 hasRelatedWork W2989731915 @default.
• W3200147166 hasRelatedWork W3021851930 @default.

• next